Neuronetics, Inc. STIM
NASDAQ
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | 20.65% | -17.53% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 20.65% | -17.53% | |||
| Cost of Revenue | 11.17% | -6.98% | |||
| Gross Profit | 31.38% | -26.92% | |||
| SG&A Expenses | -10.08% | -5.17% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -0.87% | -6.40% | |||
| Operating Income | 83.31% | -93.73% | |||
| Income Before Tax | 67.87% | -49.60% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 67.87% | -49.60% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | 350.00% | -120.83% | |||
| Net Income | 68.13% | -50.74% | |||
| EBIT | 83.31% | -93.73% | |||
| EBITDA | 90.54% | -110.11% | |||
| EPS Basic | 69.70% | -48.99% | |||
| Normalized Basic EPS | 68.19% | -50.49% | |||
| EPS Diluted | 69.70% | -48.99% | |||
| Normalized Diluted EPS | 68.19% | -50.49% | |||
| Average Basic Shares Outstanding | 5.09% | 1.21% | |||
| Average Diluted Shares Outstanding | 5.09% | 1.21% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||